eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Amoxicillin, Prednisolone, Albuterol, Omeprazole for a Female patient aged 31

This is a personalized study for a 31 year old female patient. The study is created by eHealthMe based on reports of 44 people who take the same drugs and have drug interactionsfrom FDA.

On Oct, 31, 2014: 44 people who reported to have interactions when taking Amoxicillin, Prednisolone, Albuterol, Omeprazole are studied

Trend of Amoxicillin, Prednisolone, Albuterol, Omeprazole's drug interactions, side effects, and effectiveness reports (3134721)

Information of the patient in this study:

Age: 31

Gender: female

Drugs taking:
- Amoxicillin
- Prednisolone
- Albuterol
- Omeprazole

Drug interactions have: Tinnitus, Deafness

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 31 (±5):

InteractionNumber of reports
Tinnitus (a ringing in the ears)3 (100.00%)
Deafness3 (100.00%)

Most common interactions experienced by females aged 31 (±5) in the use of Amoxicillin, Prednisolone, Albuterol, Omeprazole:

InteractionNumber of reports
Tinnitus (a ringing in the ears)3
Deafness3

Most common interactions experienced by females aged 31 (±5) in long term use of Amoxicillin, Prednisolone, Albuterol, Omeprazole:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Tinnitus (a ringing in the ears)6 (13.64%)
Deafness6 (13.64%)

Most common interactions experienced by people in the use of Amoxicillin, Prednisolone, Albuterol, Omeprazole:

InteractionNumber of reports
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)44
Hyperkalaemia (damage to or disease of the kidney)44
Renal Failure Acute (rapid kidney dysfunction)44
Tachycardia (a heart rate that exceeds the range of 100 beats/min)44
Hypertension (high blood pressure)43
Anaphylactic Reaction (serious allergic reaction)40
Pain38
Drug Interaction32
Urine Output Decreased18
Hyperhidrosis (abnormally increased sweating)18

Most common interactions experienced by people in long term use of Amoxicillin, Prednisolone, Albuterol, Omeprazole:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.